Algorithms vs. Intuition | Richard Sewoatsri
AI Strategy Clinical Risk

Algorithms vs. Intuition: The Risk Architecture of AI

Artificial Intelligence is poised to revolutionize pharmacy practice, but there is a dangerous misconception taking root in hospital boardrooms. The belief is that algorithms can replace the “administrative burden” of clinical verification.

While AI excels at data processing—flagging interactions, dosing errors, and allergies—it lacks the one critical component of patient safety: Context. An algorithm can see what is prescribed, but it cannot understand why a decision was made in the gray areas of clinical practice.

The Context Gap

Consider a patient flagged for “non-adherence” by an AI model because they haven’t refilled a prescription in 45 days. The algorithm marks this as a risk factor. A human pharmacist, however, talks to the patient and discovers they are splitting pills due to cost.

“An algorithm sees a data point. A pharmacist sees a human story. If we optimize for the data point, we miss the patient entirely.”

This is the “Context Gap.” AI cannot detect social determinants of health, subtle changes in cognitive status, or the hesitation in a patient’s voice when they say they understand discharge instructions.

The Future: Risk Architecture

The role of the pharmacist must evolve from “order verifier” to “risk architect.” In this model, AI handles the Type 1 (binary) decisions, while pharmacists handle the Type 2 (complex, high-stakes) decisions.

  • AI Role: High-volume data scanning, pattern recognition, predictive analytics.
  • Pharmacist Role: Interpretation, ethical judgment, patient advocacy, and system design.

We do not need pharmacists to act like slower computers. We need them to act like clinical risk managers who use computers to see around corners.

Richard Sewoatsri

About Richard Sewoatsri, PharmD

Richard is a Healthcare Systems Strategist helping leadership translate clinical risk into boardroom strategy. He is a former Navy Navigation Officer and currently practices at Kaiser Permanente.

Invite Richard to Speak

Read Next Insight

The $18 Billion Blind Spot: Why Medication Safety Is Your Hospital’s Hidden Balance Sheet

Similar Posts

  • Antimicrobial Stewardship ROI

    Antimicrobial Stewardship ROI | Richard Sewoatsri Stewardship Finance Antimicrobial Stewardship ROI: What CFOs Need to Know By Richard Sewoatsri | September 10, 2025 | 6 Min Read Antimicrobial resistance (AMR) is a $4.6 billion annual expense hiding in plain sight in US hospitals. Yet, when Antimicrobial Stewardship Programs (ASPs) pitch for budget, they often speak…

  • The $18 Billion Blind Spot

    The $18 Billion Blind Spot | Richard Sewoatsri Economics Patient Safety The $18 Billion Blind Spot: Why Medication Safety Is Your Hospital’s Hidden Balance Sheet By Richard Sewoatsri | October 15, 2025 | 5 Min Read Most hospital CFOs treat medication errors as a clinical compliance issue. They leave it to the Chief Medical Officer…

Leave a Reply

Your email address will not be published. Required fields are marked *